Drug Profile
BIA 102474
Alternative Names: BIA 10; BIA 10 2474Latest Information Update: 05 Apr 2016
Price :
$50
*
At a glance
- Originator BIAL
- Class Neuropsychotherapeutics
- Mechanism of Action Fatty acid amide hydrolase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Suspended Neurological disorders; Pain; Psychiatric disorders
Most Recent Events
- 11 Mar 2016 Phase-I clinical trials in Neurological disorders in Portugal (PO) before March 2016 (Bial pipeline; March 2016)
- 11 Mar 2016 Phase-I clinical trials in Psychiatric disorders in Portugal (PO) before March 2016 (Bial pipeline; March 2016)
- 11 Mar 2016 Suspended - Phase-I for Neurological disorders in Portugal (PO) before March 2016 (Bial pipeline; March 2016)